Unreported Results and Legal Risks

A recent FDA reminder revealed that nearly 30% of certain clinical trials still lack publicly reported results—raising concerns about transparency and bias in scientific research. In this episode, we explore how missing or selectively reported data can distort the scientific record and influence litigation outcomes. We break down the role of Daubert and Rule 702, and discuss how attorneys can identify gaps in the evidence to challenge expert reliability. This is a must-listen for anyone navigating the intersection of science, regulation, and the law. Read the full articleWhat the Scientific Record Leaves Out: Unreported Evidence and Expert Reliability Under Daubert About the authorGloria Malpass, Ph.D.